Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
Authors
Keywords
-
Journal
npj Schizophrenia
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-17
DOI
10.1038/s41537-021-00192-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
- (2020) Heidi Taipale et al. World Psychiatry
- T246. RISK FACTORS FOR PSYCHOTIC RELAPSE IN CHRONIC SCHIZOPHRENIA AFTER DOSE-REDUCTION OR DISCONTINUATION OF ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS
- (2020) Jan Bogers et al. SCHIZOPHRENIA BULLETIN
- The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia
- (2020) Konstantinos N. Fountoulakis et al. CNS SPECTRUMS
- Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia
- (2020) John M. Kane et al. JAMA Psychiatry
- Long‐term effectiveness of oral second‐generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta‐analysis of direct head‐to‐head comparisons
- (2019) Taishiro Kishimoto et al. World Psychiatry
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics
- (2019) Takahiro Masuda et al. JAMA Psychiatry
- Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities
- (2019) Amanda Krogmann et al. CNS SPECTRUMS
- Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
- (2019) Hideaki Tani et al. NEUROPSYCHOPHARMACOLOGY
- Ranking Antipsychotics for Efficacy and Safety in Schizophrenia
- (2019) Christoph U. Correll et al. JAMA Psychiatry
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
- (2019) Thomas RE Barnes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
- (2018) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
- (2018) Marc Krause et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials
- (2018) Myrto T Samara et al. SCHIZOPHRENIA BULLETIN
- What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
- (2018) Christoph U. Correll et al. World Psychiatry
- ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials
- (2018) Gang Wang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-analysis
- (2017) Yikang Zhu et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia – a short version for primary care
- (2017) Alkomiet Hasan et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies
- (2017) Taishiro Kishimoto et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis
- (2017) Britta Galling et al. World Psychiatry
- Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia
- (2017) Christoph U. Correll et al. JAMA Psychiatry
- Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia
- (2017) Heidi Taipale et al. SCHIZOPHRENIA RESEARCH
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders
- (2016) Cherrie Galletly et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
- (2016) Dan Siskind et al. BRITISH JOURNAL OF PSYCHIATRY
- The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
- (2016) Christoph U. Correll et al. JOURNAL OF CLINICAL PSYCHIATRY
- Altering the course of schizophrenia: progress and perspectives
- (2016) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia
- (2015) Andreas Schreiner et al. SCHIZOPHRENIA RESEARCH
- Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia
- (2015) Kenneth L. Subotnik et al. JAMA Psychiatry
- Schizophrenia
- (2015) René S. Kahn et al. Nature Reviews Disease Primers
- Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
- (2013) Pierre Michel Llorca et al. BMC Psychiatry
- The nature of relapse in schizophrenia
- (2013) Robin Emsley et al. BMC Psychiatry
- Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry
- (2013) John M. Kane et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia
- (2013) Taishiro Kishimoto et al. JOURNAL OF CLINICAL PSYCHIATRY
- Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies
- (2013) John M. Kane et al. World Psychiatry
- A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia
- (2012) Marco DiBonaventura et al. BMC Psychiatry
- Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis
- (2012) Jian-Ping Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials
- (2012) T. Kishimoto et al. SCHIZOPHRENIA BULLETIN
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
- (2011) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
- (2011) Thomas RE Barnes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics
- (2011) T Kishimoto et al. MOLECULAR PSYCHIATRY
- The Italian guidelines for early intervention in schizophrenia: development and conclusions
- (2010) Salvatore De Masi et al. Early Intervention in Psychiatry
- Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA BULLETIN
- Understanding Needs, Interactions, Treatment, and Expectations Among Individuals Affected by Bipolar Disorder or Schizophrenia
- (2009) Roger S. McIntyre JOURNAL OF CLINICAL PSYCHIATRY
- Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
- (2009) Hiroyuki Uchida et al. SCHIZOPHRENIA BULLETIN
- The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
- (2009) Julie Kreyenbuhl et al. SCHIZOPHRENIA BULLETIN
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
- (2009) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More